Trexquant Investment »

Atea Pharmaceuticals shares owned by Trexquant Investment

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $69k 15k 4.65

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Capital Management
Bain Capital Life Sciences Investors
Acadian Asset Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Dimensional Fund Advisors
Renaissance Technologies
Rosalind Advisors
Jpmorgan Chase & Co
Northern Trust

View all funds holding Atea Pharmaceuticals